跳至主要内容
临床试验/NCT02778659
NCT02778659已完成不适用

The Effect of Acute Hypnotic Intake Before a Night at High Altitude on Cognitive and Motor Performances

Centre d'Expertise sur l'Altitude EXALT1 个研究点 分布在 1 个国家目标入组 22 人开始时间: 2016年5月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
22
试验地点
1
主要终点
Cognitive performance assessed using Simon cognitive test

研究概览

简要总结

This study aims to determine the effect of acute hypnotic intake (Zolpidem) on sleep, cognitive and motor performances and on acute mountain sickness symptoms at high altitude. Healthy subjects will be evaluated on 4 occasions (twice at sea level and twice at high altitude), after hypnotic or placebo intake. Following an early wake-up (01:00), symptoms, cognitive and motor performances will be assessed to determine potential residual effects of Zolpidem within such conditions.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Basic Science
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • No sojourn above 2500 m during the past 2 months
  • Coffee intake < 3 cups per day
  • Non-smoker

排除标准

  • Respiratory, cardiovascular, metabolic or neuromuscular diseases
  • Psychiatric disorders
  • Use of hypnotics within the past year
  • Dependence syndrome (alcool, drugs, etc)
  • Severe insomnia or somnolence

研究组 & 干预措施

Zolpidem Normoxia

Experimental

Acute zolpidem intake at sea level

干预措施: Zolpidem (Drug)

Placebo Normoxia

Sham Comparator

Acute placebo intake at sea level

干预措施: Placebo (Drug)

Zolpidem Hypoxia

Experimental

Acute zolpidem intake at high altitude

干预措施: Zolpidem (Drug)

Placebo Hypoxia

Sham Comparator

Acute placebo intake at high altitude

干预措施: Placebo (Drug)

结局指标

主要结局

Cognitive performance assessed using Simon cognitive test

时间窗: 4 hours after drug/placebo intake

Simon cognitive test

次要结局

未报告次要终点

研究者

发起方
Centre d'Expertise sur l'Altitude EXALT
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验